Avarieux
back to explore
AtaiBeckley Inc logo

ATAI

AtaiBeckley Inc
NASDAQ NMS - GLOBAL MARKET· Pharmaceuticals· US· IPO 2021-06-18
$7.35
+0.01 (+0.14%)
last quote
Want the full multi-source brief on ATAI?
The agent pulls regulatory filings, news flow, prediction-market pricing, and macro context — then synthesizes what's not yet in the price.
open in agent
Today
Open
$7.35
High
$7.36
Low
$7.32
Previous close
$7.34
Fundamentals
Market cap
$2.69B
P/E (TTM)
—
P/S (TTM)
770.86x
P/B
6.70x
Gross margin
—
Operating margin
-18569.09%
Net margin
-19019.44%
Rev growth (YoY)
86.72%
EPS growth (YoY)
—
ROE
-366.49%
52W high
$7.45
52W low
$3.27
Beta
1.65x
Industry peers
by market cap
TARS+11.76%OGN+0.07%GPCR+1.42%MBX-0.07%SUPN+0.66%PBH+0.36%HRMY+3.90%CURA.TO
Recent SEC filings
CIK 2081043filing-language history →
8-K2026-08-31
163 KB
10-Q2026-08-11reports 2026-06-30
19,919 KB
DEFM14A2026-08-10
4,359 KB
PREM14A2026-07-30reports 2026-07-29
4,586 KB
SCHEDULE 13G2026-07-27
11 KB
SCHEDULE 13D/A2026-07-17
20 KB
Recent news
2026-08-27 → 2026-09-03
Benzinga · 2d
AtaiBeckley Says Hart-Scott-Rodino Waiting Period For Merger With Eli Lilly Expired On Aug 28, 2026; UK Competition Authority Has No Further Questions On Merger As Of August 21, 2026
As previously disclosed, AtaiBeckley Inc. (the "Company") entered into an Agreement and Plan of Merger, dated as of July 15, 2026 (the "Merger Agreement"), with Eli Lilly and Company, an Indiana
SEC EDGAR Yahoo Finance TradingView Company website
This is the free preview

The agent layer adds regulatory-language drift detection, cross-venue prediction-market signals, macro overlays, programmable alert rules, overnight briefs, and a grounding verifier on every claim. 7-day Pro trial, no card required.

Start the trial